Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
This study is currently recruiting participants.
Study NCT00068601 Information provided by National Cancer Institute (NCI)
First Received: September 10, 2003 Last Updated: November 5, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Menopausal Symptoms
Sexual Dysfunction and Infertility
Additional conditions recognized in this trial
Breast Neoplasms
Infertility
Ovarian Failure, Premature
More general conditions related to this trial
Adnexal Diseases
Breast Diseases
Endocrine System Diseases
Genital Diseases, Female
Genital Diseases, Male
Gonadal Disorders
Neoplasms
Neoplasms by Site
Ovarian Diseases
Skin Diseases
Interventions listed in this trial
cyclophosphamide
goserelin
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Southwest Oncology Group
National Cancer Institute (NCI)
Cancer and Leukemia Group B
Eastern Cooperative Oncology Group
International Breast Cancer Study Group
Back to top of Main Content
